Overview
Status
Active
Registry date
2022-08-22
Share capital
50,000.00 PLN
Registered address
ul. Jana Dantyszka 18, 02-054 Warszawa, Poland
Electronic delivery address
AE:PL-36451-66212-AJUWA-20
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 82 days early.
- 202521/04/2026
- 202425/04/2025
- 202325/04/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 8.75kMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD 3.64kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 5.06kMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 7.63kMedianUSD 897.46kAverageUSD 31.52m
Industry
Authorized Representatives
Tetiana Sheinich – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marharyta Bondarievaage 26 | 330 | $4,457.05 | 33% |
Iryna Goncharovaage 58 | 330 | $4,457.05 | 33% |
Tetiana Sheinichage 50 | 340 | $4,592.11 | 34% |
Beneficial owners
No beneficial owners recorded for the company T.M.I..
Bank accounts
Registered as a VAT taxpayer on 2022-09-06.
06 1090 1883 0000 0001 5138 8749
11 1090 1883 0000 0001 5138 8853
89 1090 1883 0000 0001 5138 8807
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
FAQ
The main business activity of T.M.I. focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on August 22, 2022.
The headquarters is located at: ul. Jana Dantyszka 18, 02-054 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
Last updated: 2026-04-21